Diabetes risk score: towards earlier detection of type 2 diabetes in general practice - PubMed (original) (raw)
Diabetes risk score: towards earlier detection of type 2 diabetes in general practice
S J Griffin et al. Diabetes Metab Res Rev. 2000 May-Jun.
Abstract
Background: Type 2 diabetes is common, costly and often goes unrecognised for many years. When patients are diagnosed, the majority exhibit associated tissue damage or established cardiovascular risk. Evidence is accumulating that earlier detection and management of diabetes and related metabolic abnormalities may be beneficial. We aimed to develop and evaluate a score based on routinely collected information to identify people at risk of having undetected diabetes.
Methods: A population-based sample of 1077 people, aged 40 to 64 years, without known diabetes, from a single Cambridgeshire general practice, underwent clinical assessment including an oral glucose tolerance test. In a separate 12-month study, 41 practices in southern England reported clinical details of patients aged 40 to 64 years with newly diagnosed Type 2 diabetes. A notional population was created by random selection and pooling of half of each dataset. Data were entered into a regression model to produce a formula predicting the risk of diabetes. The performance of this risk score in detecting diabetes was tested in an independent, randomly selected, population-based sample.
Results: Age, gender, body mass index, steroid and antihypertensive medication, family and smoking history contributed to the score. In the test population at 72% specificity, the sensitivity of the score was 77% and likelihood ratio 2.76. The area under the receiver-operating characteristic curve was 80%.
Conclusions: A simple score, using only data that are routinely collected in general practice, can help identify those at risk of diabetes. This score could contribute to efficient earlier detection through case-finding or targeted screening.
Copyright 2000 John Wiley & Sons, Ltd.
Similar articles
- Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.
Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J. Saaristo T, et al. Diab Vasc Dis Res. 2005 May;2(2):67-72. doi: 10.3132/dvdr.2005.011. Diab Vasc Dis Res. 2005. PMID: 16305061 - The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting.
Gray LJ, Taub NA, Khunti K, Gardiner E, Hiles S, Webb DR, Srinivasan BT, Davies MJ. Gray LJ, et al. Diabet Med. 2010 Aug;27(8):887-95. doi: 10.1111/j.1464-5491.2010.03037.x. Diabet Med. 2010. PMID: 20653746 - Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, Tognoni G, Valentini M, Nicolucci A. Franciosi M, et al. Diabetes Care. 2005 May;28(5):1187-94. doi: 10.2337/diacare.28.5.1187. Diabetes Care. 2005. PMID: 15855587 - A Colombian diabetes risk score for detecting undiagnosed diabetes and impaired glucose regulation.
Barengo NC, Tamayo DC, Tono T, Tuomilehto J. Barengo NC, et al. Prim Care Diabetes. 2017 Feb;11(1):86-93. doi: 10.1016/j.pcd.2016.09.004. Epub 2016 Oct 7. Prim Care Diabetes. 2017. PMID: 27727004 - Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].
LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. LeBlanc EL, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. PMID: 30354042 Free Books & Documents. Review.
Cited by
- Genetic Risk Score Increased Discriminant Efficiency of Predictive Models for Type 2 Diabetes Mellitus Using Machine Learning: Cohort Study.
Wang Y, Zhang L, Niu M, Li R, Tu R, Liu X, Hou J, Mao Z, Wang Z, Wang C. Wang Y, et al. Front Public Health. 2021 Feb 17;9:606711. doi: 10.3389/fpubh.2021.606711. eCollection 2021. Front Public Health. 2021. PMID: 33681127 Free PMC article. - Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study.
Chamnan P, Simmons RK, Khaw KT, Wareham NJ, Griffin SJ. Chamnan P, et al. Diabet Med. 2012 Jul;29(7):893-904. doi: 10.1111/j.1464-5491.2012.03609.x. Diabet Med. 2012. PMID: 22340130 Free PMC article. - Effect of communicating genetic and phenotypic risk for type 2 diabetes in combination with lifestyle advice on objectively measured physical activity: protocol of a randomised controlled trial.
Godino JG, van Sluijs EM, Marteau TM, Sutton S, Sharp SJ, Griffin SJ. Godino JG, et al. BMC Public Health. 2012 Jun 18;12:444. doi: 10.1186/1471-2458-12-444. BMC Public Health. 2012. PMID: 22708638 Free PMC article. Clinical Trial. - More than measurement: practice team experiences of screening for type 2 diabetes.
Graffy J, Grant J, Williams K, Cohn S, Macbay S, Griffin S, Kinmonth AL. Graffy J, et al. Fam Pract. 2010 Aug;27(4):386-94. doi: 10.1093/fampra/cmq022. Epub 2010 Apr 19. Fam Pract. 2010. PMID: 20403926 Free PMC article. Clinical Trial. - Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk.
Kootar S, Huque MH, Kiely KM, Anderson CS, Jorm L, Kivipelto M, Lautenschlager NT, Matthews F, Shaw JE, Whitmer RA, Peters R, Anstey KJ. Kootar S, et al. BMJ Open. 2023 Sep 22;13(9):e076860. doi: 10.1136/bmjopen-2023-076860. BMJ Open. 2023. PMID: 37739460 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical